DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Experimental and molecular pathology (Print)

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexmp.2013.07.004PMID 23872438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains.

  2011cited by this paper
• Novel Immunotherapeutic Agents and Small Molecule Antagonists of Signalling Kinases for the Treatment of Metastatic Melanoma

  2011cited by this paper
• Depletion of human regulatory T cells.

  2011cited by this paper
• The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF

  2011cited by this paper
• Regulatory role of resveratrol on Th17 in autoimmune disease.

  2011cited by this paper
• Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis

  2011cited by this paper
• Regulatory T Cells: Overcoming Suppression of T-Cell Immunity

  2010cited by this paper
• Targeted therapies: Denileukin diftitox—a step towards a 'magic bullet' for CTCL

  2010cited by this paper
• Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.

  2010cited by this paper
• Suppression of murine experimental autoimmune encephalomyelitis by interleukin-2 receptor targeted fusion toxin, DAB(389)IL-2.

  2010cited by this paper
• Comparative methodologies of regulatory T cell depletion in a murine melanoma model.

  2008cited by this paper
• IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity.

  2007cited by this paper
• Microglial recruitment, activation, and proliferation in response to primary demyelination.

  2007cited by this paper
• Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.

  2007cited by this paper
• Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls.

  2007cited by this paper
• Antigen Presentation in the CNS by Myeloid Dendritic Cells Drives Progression of Relapsing Experimental Autoimmune Encephalomyelitis

  2007cited by this paper
• Monoclonal Antibody against T‐Cell Receptor αβ Induces Self‐Tolerance in Chronic Experimental Autoimmune Encephalomyelitis

  2007cited by this paper
• p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.

  2007cited by this paper
• Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties

  2006cited by this paper
• A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis

  2006cited by this paper
• Phenotypic characterization of autoreactive T cells in multiple sclerosis.

  2006cited by this paper
• Requirement of high-affinity IL-2-IL-2R interaction for T cell anergy induction.

  2006cited by this paper
• Altered CD 4 / CD 8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

  2006cited by this paper
• Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.

  2006cited by this paper
• Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing‐remitting multiple sclerosis: thymic versus peripheral (non‐thymic) mechanisms

  2006cited by this paper
• Analyses of TCR clustering at the T cell-antigen-presenting cell interface and its impact on the activation of naive CD4+ T cells.

  2006cited by this paper
• Microglial cell activation and proliferation precedes the onset of CNS autoimmunity

  2005cited by this paper
• Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis

  2005cited by this paper
• The role of CD8(+) T cells in multiple sclerosis and its animal models.

  2005cited by this paper
• γδ T Cell Regulation of IFN-γ Production by Central Nervous System-Infiltrating Encephalitogenic T Cells: Correlation with Recovery from Experimental Autoimmune Encephalomyelitis1

  2004cited by this paper
• Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.

  2004cited by this paper
• Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin

  2003cited by this paper
• gamma/delta T cells in multiple sclerosis: chemokine and chemokine receptor expression.

  2002cited by this paper
• Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression.

  2002cited by this paper
• gammadelta T cells express activation markers in the central nervous system of mice with chronic-relapsing experimental autoimmune encephalomyelitis.

  2001cited by this paper
• Resident and Infiltrating Central Nervous System APCs Regulate the Emergence and Resolution of Experimental Autoimmune Encephalomyelitis1

  2001cited by this paper
• γδ T Cells Express Activation Markers in the Central Nervous System of Mice with Chronic-relapsing Experimental Autoimmune Encephalomyelitis

  2001cited by this paper
• Experimental allergic neuritis in the SJL/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12.

  2000cited by this paper
• Ia expression and antigen presentation by glia: strain and cell type-specific differences among rat astrocytes and microglia.

  1997cited by this paper
• Mice lacking αβ+ T cells are resistant to the induction of experimental autoimmune encephalomyelitis

  1996cited by this paper
• Mice lacking alpha beta + T cells are resistant to the induction of experimental autoimmune encephalomyelitis.

  1996cited by this paper
• The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis

  1995cited by this paper
• Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune transferred experimental autoimmune encephalomyelitis: An investigation using rat radiation bone marrow chimeras

  1995cited by this paper
• Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: an investigation using rat radiation bone marrow chimeras.

  1995cited by this paper
• Suppression of immunopathology in schistosomiasis by interleukin-2-targeted fusion toxin, DAB389IL-2. I. Studies of in vitro and in vivo efficacy.

  1995cited by this paper
• Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.

  1995cited by this paper
• Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis

  1994cited by this paper
• Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis.

  1994cited by this paper
• A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats.

  1994cited by this paper
• Anti‐arthritic effects demonstrated by an interleukin‐2 receptor‐targeted cytotoxin (DAB486IL‐2) in rat adjuvant arthritis

  1992cited by this paper
• Interleukin 2 receptor targeted fusion toxin (DAB486‐IL‐2) treatment blocks diabetogenic autoimmunity in non‐obese diabetic mice

  1992cited by this paper
• Induction of anti‐myelin antibodies in EAE and their possible role in demyelination

  1991cited by this paper
• Impact of interleukin‐2‐receptor‐targeted cytotoxins on a unique model of murine interleukin‐2‐receptor‐expressing malignancy

  1991cited by this paper
• Suppression of immune responses to acetylcholine receptor by interleukin 2-fusion toxin: in vivo and in vitro studies.

  1991cited by this paper
• Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein.

  1990cited by this paper
• Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells.

  1990cited by this paper
• Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194.

  1990cited by this paper
• Characteristics of in vitro cytotoxic effects of myelin basic protein-reactive T cell lines on syngeneic oligodendrocytes

  1990cited by this paper
• New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury.

  1990cited by this paper
• Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor- mediated action of a diphtheria toxin-related interleukin 2 fusion protein

  1988cited by this paper
• Cytotoxic effect of myelin basic protein-reactive T cells on cultured oligodendrocytes

  1988cited by this paper
• Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein.

  1987cited by this paper
• Antigen-specific T cells can mediate demyelination in organotypic central nervous system cultures.

  1986cited by this paper
• Preliminary analysis of cell and serum‐induced demyelination in vitro using a syngeneic system

  1985cited by this paper
• Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

  1972cited by this paper
• Cancer Management and Research Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Role of Denileukin Diftitox in the Treatment of Persistent or Recurrent Cutaneous T-cell Lymphoma

  year unknowncited by this paper

• Interleukin-2 Family Members and their Role in Demyelinating Disease

  2020cites this paper
• Chlamydia muridarum infection induces CD4+ T cells apoptosis via PI3K/AKT signal pathway.

  2019cites this paper
• DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice

  2017cites this paper
• Sleep Loss as a Factor to Induce Cellular and Molecular Inflammatory Variations

  2013cites this paper